42
Views
34
CrossRef citations to date
0
Altmetric
Original

Remission and Survival Following Monthly Intraarterial Cisplatinum in Nonresectable Hepatoma

, Ph.D., M.D., , M.D., Sc.D., , Ph.D., , M.D., , M.D., , D.O., & , M.D. show all
Pages 613-625 | Published online: 17 Jul 2002

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Masaki Kaibori, Hideyuki Matsushima, Morihiko Ishizaki, Hisashi Kosaka, Kosuke Matsui, Miyuki Nakatani, Shuji Kariya, Takashi Yamaguchi, Katsunori Yoshida, Kengo Yoshii & Mitsugu Sekimoto. (2022) The Impact of Sorafenib in Combination with Intermittent Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with Major Vascular Invasion. Cancer Investigation 40:1, pages 81-89.
Read now
Morihiko Ishizaki, Masaki Kaibori, Kosuke Matsui, Hiroki Ikeda, Katsunori Yoshida, Kazuichi Okazaki, Syuji Kariya, Noboru Tanigawa, Richi Nakatake, Hideyuki Matsushima, Tatsuma Sakaguchi & Masanori Kon. (2017) Phase I Study of Sorafenib in Combination with Intermittent Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma. Cancer Investigation 35:4, pages 271-276.
Read now
George P Kim & Charles Erlichman. (2007) Oxaliplatin in the treatment of colorectal cancer. Expert Opinion on Drug Metabolism & Toxicology 3:2, pages 281-294.
Read now

Articles from other publishers (31)

Naoto Kawabe, Senju Hashimoto, Takuji Nakano, Kazunori Nakaoka, Aiko Fukui & Kentaro Yoshioka. (2021) Transcatheter arterial infusion chemotherapy with cisplatin in combination with transcatheter arterial chemoembolization decreases intrahepatic distant recurrence of unresectable hepatocellular carcinoma. JGH Open 5:6, pages 705-711.
Crossref
Yumi Kosaka, Tomoki Kimura, Tomokazu Kawaoka, Yutaro Ogawa, Kei Amioka, Kensuke Naruto, Yuki Yoshikawa, Chihiro Kikukawa, Yosuke Suehiro, Kenji Yamaoka, Yuwa Ando, Shinsuke Uchikawa, Kei Morio, Takashi Nakahara, Eisuke Murakami, Shoichi Takahashi, Masataka Tsuge, Akira Hiramatsu, Michio Imamura, Keigo Chosa, Kazuo Awai, Yasushi Nagata, Kazuaki Chayama & Hiroshi Aikata. (2021) Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein. Liver Cancer 10:2, pages 151-160.
Crossref
Masaaki Kondo, Manabu Morimoto, Satoshi Kobayashi, Shinichi Ohkawa, Hisashi Hidaka, Takahide Nakazawa, Hiroshi Aikata, Takeshi Hatanaka, Daichi Takizawa, Kotaro Matsunaga, Chiaki Okuse, Michihiro Suzuki, Masataka Taguri, Takako Ishibashi, Kazushi Numata, Shin Maeda & Katsuaki Tanaka. (2019) Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial. BMC Cancer 19:1.
Crossref
Tomokazu Kawaoka, Hiroshi Aikata, Tomoki Kobayashi, Shinsuke Uchikawa, Kazuki Ohya, Kenichiro Kodama, Yuno Nishida, Kana Daijo, Mitsutaka Osawa, Yuji Teraoka, Yuki Inagaki, Fumi Honda, Masahiro Hatooka, Kei Morio, Reona Morio, Hatsue Fujino, Takashi Nakahara, Eisuke Murakami, Masataka Tsuge, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Yasutaka Baba, Kazuo Awai & Kazuaki Chayama. (2018) Comparison of hepatic arterial infusion chemotherapy between 5-fluorouracil-based continuous infusion chemotherapy and low-dose cisplatin monotherapy for advanced hepatocellular carcinoma. Hepatology Research 48:13, pages 1118-1130.
Crossref
Masafumi Ikeda, Chigusa Morizane, Makoto Ueno, Takuji Okusaka, Hiroshi Ishii & Junji Furuse. (2018) Chemotherapy for hepatocellular carcinoma: current status and future perspectives. Japanese Journal of Clinical Oncology 48:2, pages 103-114.
Crossref
Takeshi Hatanaka, Satoru Kakizaki, Yasushi Shimada, Daichi Takizawa, Kenji Katakai, Yuichi Yamazaki, Ken Sato, Motoyasu Kusano & Masanobu Yamada. (2016) Early Decreases in ?-Fetoprotein and Des-?-carboxy Prothrombin Predict the Antitumor Effects of Hepatic Transarterial Infusion Chemotherapy with Cisplatin (CDDP) Powder in Patients with Advanced Hepatocellular Carcinoma. Internal Medicine 55:16, pages 2163-2171.
Crossref
Junya Hashizume, Norihide Higuchi, Kayoko Sato, Yukinobu Kodama, Noriko Matsunaga, Toshiaki Sakamoto, Kentaro Yamaguchi, Tadahiro Nakamura, Takashi Kitahara & Hitoshi Sasaki. (2016) Evaluation of Antiemetic Therapy for Hepatic Transcatheter Arterial Infusion Chemotherapy with Cisplatin. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 39:4, pages 611-614.
Crossref
Masafumi Ikeda, Shuichi Mitsunaga, Satoshi Shimizu, Izumi Ohno, Hideaki Takahashi, Hiroyuki Okuyama, Akiko Kuwahara, Shunsuke Kondo, Chigusa Morizane, Hideki Ueno, Mitsuo Satake, Yasuaki Arai & Takuji Okusaka. (2013) Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization. Journal of Gastroenterology 49:5, pages 932-940.
Crossref
Atsushi Hagihara, Masafumi Ikeda, Hideki Ueno, Chigusa Morizane, Shunsuke Kondo, Kohei Nakachi, Shuichi Mitsunaga, Satoshi Shimizu, Yasushi Kojima, Eiichiro Suzuki, Kazuhiro Katayama, Kazuho Imanaka, Chie Tamai, Yoshitaka Inaba, Yozo Sato, Mina Kato & Takuji Okusaka. (2014) Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma. Cancer Science 105:3, pages 354-358.
Crossref
Nao Fushiya, Ichiro Takagi, Hirokazu Nishino, Setsuko Akizuki & Akihiro Ohnishi. (2013) Genetic polymorphisms of enzymes related to oral tegafur/uracil therapeutic efficacy in patients with hepatocellular carcinoma. Anti-Cancer Drugs 24:6, pages 617-622.
Crossref
Kazuhiro Nouso. (2013) Current chemotherapies for advanced hepatocellular carcinoma. Clinical Journal of Gastroenterology 6:2, pages 89-93.
Crossref
Akihiko Osaki, Takeshi Suda, Kenya Kamimura, Atsunori Tsuchiya, Yasushi Tamura, Masaaki Takamura, Masato Igarashi, Hirokazu Kawai, Satoshi Yamagiwa & Yutaka Aoyagi. (2013) A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma. Cancer Medicine 2:1, pages 86-98.
Crossref
Seiji Oguro, Satoshi Nara, Shunsuke Kondo, Shutaro Hori, Yoji Kishi, Minoru Esaki, Kazuaki Shimada, Tomoo Kosuge, Takuji Okusaka & Hidenori Ojima. (2013) A Case of Pathological Complete Response after Combination Chemotherapy by Sorafenib and Cisplatin Hepatic Arterial Infusion for an Advanced Hepatocellular Carcinoma. The Japanese Journal of Gastroenterological Surgery 46:12, pages 915-923.
Crossref
Kenya Kamimura, Takeshi Suda, Yasushi Tamura, Masaaki Takamura, Takeshi Yokoo, Masato Igarashi, Hirokazu Kawai, Satoshi Yamagiwa, Minoru Nomoto & Yutaka Aoyagi. (2012) Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma. BMC Gastroenterology 12:1.
Crossref
Tatsuya Yamashita. (2012) Current Status of Hepatocellular Carcinoma Treatment in Japan. Clinical Drug Investigation 32, pages 15-23.
Crossref
Tatsuya Yamashita. (2013) Current Status of Hepatocellular Carcinoma Treatment in Japan. Clinical Drug Investigation 32:S2, pages 15-23.
Crossref
Hiroki Nishikawa, Yukio Osaki, Ryuichi Kita & Toru Kimura. (2012) Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan. Cancers 4:1, pages 165-183.
Crossref
Sung Gwe Ahn, Sung Hoon Kim, Tae Joo Jeon, Ho Jin Cho, Sae Byeol Choi, Mi Jin Yun, Jong Doo Lee & Kyung Sik Kim. (2011) The Role of Preoperative [18F]Fluorodeoxyglucose Positron Emission Tomography in Predicting Early Recurrence After Curative Resection of Hepatocellular Carcinomas. Journal of Gastrointestinal Surgery 15:11, pages 2044-2052.
Crossref
Toru Ishikawa, Kazuo Higuchi, Tomoyuki Kubota, Keiichi Seki, Terasu Honma, Toshiaki Yoshida & Tomoteru Kamimura. (2011) Prevention of intrahepatic distant recurrence by transcatheter arterial infusion chemotherapy with platinum agents for stage I/II hepatocellular carcinoma. Cancer 117:17, pages 4018-4025.
Crossref
Tatsuya Yamashita, Kuniaki Arai, Hajime Sunagozaka, Teruyuki Ueda, Takeshi Terashima, Taro Yamashita, Eishiro Mizukoshi, Akito Sakai, Yasunari Nakamoto, Masao Honda & Shuichi Kaneko. (2011) Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma. Oncology 81:5-6, pages 281-290.
Crossref
M. Kondo, M. Morimoto, K. Numata, A. Nozaki & K. Tanaka. (2010) Hepatic Arterial Infusion Therapy with a Fine Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Japanese Journal of Clinical Oncology 41:1, pages 69-75.
Crossref
Shigeki Arii, Michio Sata, Michiie Sakamoto, Mitsuo Shimada, Takashi Kumada, Shuichiro Shiina, Tatsuya Yamashita, Norihiro Kokudo, Masatoshi Tanaka, Tadatoshi Takayama & Masatoshi Kudo. (2010) Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatology Research 40:7, pages 667-685.
Crossref
. (2010) Chapter 4: Chemotherapy and radiotherapy. Hepatology Research 40, pages 74-95.
Crossref
Masamichi Moriguchi, Tadatoshi Takayama, Masahiko Nakamura, Osamu Aramaki, Tokio Higaki, Hisashi Nakayama, Takao Ohkubo & Masashi Fujii. (2010) Phase I/II study of a fine-powder formulation of cisplatin for transcatheter arterial chemoembolization in hepatocellular carcinoma. Hepatology Research 40:4, pages 369-375.
Crossref
Toru Ishikawa. (2009) Future perspectives on the treatment of hepatocellular carcinoma with cisplatin. World Journal of Hepatology 1:1, pages 8.
Crossref
A.N. Gangopadhyay, Rahi Rajeev, S.P. Sharma, Vijai D. Upadhyaya, N.C. Arya, Vijayendra Kumar & S.C. Gopal. (2008) Anterior Intratumoural Chemotherapy: A Newer Modality of Treatment in Advanced Solid Tumours in Children. Asian Journal of Surgery 31:4, pages 225-229.
Crossref
Masaharu Yoshikawa, Naofumi Ono, Hiraku Yodono, Takafumi Ichida & Hironobu Nakamura. (2008) Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma. Hepatology Research 38:5, pages 474-483.
Crossref
Takayuki Hayashi, Tatsushi Kobayashi, Satoru Takaoka, Ryoko Iwata, Hirohumi Kuno, Eiichirou Suzuki, Kohei Nakaji & Mitsuo Satake. (2008) Analysis of transcatheter arterial infusion chemotherapy of cisplatin in advanced hepatocellular carcinoma: relationship between imaging findings (contrast-enhanced CT and angiography) and the results of TAI. Kanzo 49:10, pages 461-469.
Crossref
Kiyoshi Matsueda, Seigo Yukisawa, Teruko Ueno, Yoshimasa Fujiwara, Naoya Gomi & Kouichi Takano. (2007) Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma. Drug Delivery System 22:5, pages 537-543.
Crossref
Jean-Luc Raoul, Eveline Boucher, Damien Olivie, Anne Guillygomarc?h, Karim Boudjema & Etienne Garin. (2006) Association of cisplatin and intra-arterial injection of 131I-lipiodol in treatment of hepatocellular carcinoma: Results of phase II trial. International Journal of Radiation Oncology*Biology*Physics 64:3, pages 745-750.
Crossref
Daniel H. Palmer & David J. Kerr. 2005. Cancer Gene Therapy. Cancer Gene Therapy 109 128 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.